On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man

  • W. Meuldermans
  • R. Hurkmans
  • E. Swysen
  • J. Hendrickx
  • M. Michiels
  • W. Lauwers
  • J. Heykants
Original Papers

Summary

The excretion and metabolism of the novel gastrokinetic and antinauseant drug domperidone were studied after oral administration of the14C-labelled compound to rats, dogs and man, and after intravenous administration to rats and dogs.

Excretion of the radioactivity was almost complete within four days. In the three species, the radioactivity was excreted for the greater part with the faeces. Biliary excretion of the radioactivity amounted to 65% of the dose 24 hours after intravenous administration in rats.

Unchanged domperidone as determined by radioimmunoassay, accounted in urine for 0.3% in dogs, 0.4% in man, and in faeces for 9% in dogs and 7% in man. The main metabolic pathways of domperidone in the three species were the aromatic hydroxylation at the benzimidazolone moiety, resulting in hydroxy-domperidone -the main faecal metabolite-, and the oxidativeN-dealkylation at the piperidine nitrogen, resulting in 2,3-dihydro-2-oxo-1H-benzamidazole-1-propanoic acid the major radioactive urinary metabolite- and 5-chloro-4-piperidinyl-1,3-dihydro-benzimidazol-2-one. In urine the two first metabolites were present partly as conjugates.

A mass balance for the major metabolites in urine, faeces, bile and plasma samples was made up after radio-HPLC (reversephase HPLC with on-line radioactivity detection) of various extracts. Only minor species differences were detected.

Key words

Domperidone gastrokinetic excretion metabolism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reyntjens A., Niemegeers C., Van Nueten J., Laduron P., Heykants J., Schellekens K., Marsboom R., Jageneau A., Broekaert A. and Janssen P. (1978): Domperidone, a novel and safe gastrokinetic and antinauseant for the treatment of dyspepsia and vomiting. Arzneimittel-Forsch.,28, 1194–1196.Google Scholar
  2. 2.
    Heykants J., Knaeps A., Meuldermans W. and Michiels M. (1980): On the pharmacokinetics of domperidone in animals and man I. Plasma levels of domperidone in rats and dogs. Age-related absorption and passage through the blood-brain barrier in rats. Europ. J. Drug Metab. Pharmacokin.Google Scholar
  3. 3.
    Heykants J., Hendriks R., Meuldermans W., Michiels M. and Reyntjens A. (1980): On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. Europ. J. Drug Metab. Pharmacokin.Google Scholar
  4. 4.
    Michiels M., Hendriks R. and Heykants J. (1980): A sensitive and specific radioimmunoassay procedure for domperidone (submitted).Google Scholar
  5. 5.
    Smith R.L. (1973): The excretory function of bile, chapters 3 and 4. Chapman and Hall Ltd., London.Google Scholar
  6. 6.
    Tyler T.R., Lee J.T., Flynn H. and Vandenheuvel W.J.A. (1976): Identification of 5-hydroxybenzimidazole as a major urinary metabolite of benzimidazole in the rat. Drug Metab. Disp.,4, 177–179.Google Scholar
  7. 7.
    Michiels M., Hendriks R. and Heykants J. (1980): On the pharmacokinetics of domperidone in animals and man. II. Tissue distribution, placental and milk transfer of domperidone in the Wistar rat. Europ. J. Drug Metab. Pharmacokin.Google Scholar
  8. 8.
    Heykants J., Meuldermans W. and Michiels M. (1978): Absorption, excretion and metabolism of oral bromperidol in rats and dogs. Europ. J. Drug Metab. Pharmacokin.3, 111–117.CrossRefGoogle Scholar
  9. 9.
    Heykants J., Meuldermans W., Knaeps F. and Michiels M. (1977): The excretion and metabolism of the antidiarrheal loperamide in the Wistar rat. Europ. J. Drug Metab. Pharmacokin.,2, 81–91.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • W. Meuldermans
    • 1
    • 2
  • R. Hurkmans
    • 1
    • 2
  • E. Swysen
    • 1
    • 2
  • J. Hendrickx
    • 1
    • 2
  • M. Michiels
    • 1
    • 2
  • W. Lauwers
    • 1
    • 2
  • J. Heykants
    • 1
    • 2
  1. 1.Department of Drug Metabolism and PharmacokineticsJanssen PharmaceuticaBeerseBelgium
  2. 2.Analytical DepartmentJanssen PharmaceuticaBeerseBelgium

Personalised recommendations